Ending an HIV epidemic among persons who inject drugs in a middle-income country: extremely low HIV incidence among persons who inject drugs in Hai Phong, Viet Nam.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
01 12 2020
01 12 2020
Historique:
pubmed:
14
10
2020
medline:
18
2
2021
entrez:
13
10
2020
Statut:
ppublish
Résumé
To determine whether it is possible to 'end an HIV epidemic' among persons who inject drugs (PWID) in a low/middle income country. Serial cross-sectional surveys with a cohort of HIV seronegative participants with 6-month follow-up visits recruited from surveys. Surveys of PWID using respondent driven and snowball sampling were conducted in 2016, 2017, 2018, and 2019 (N = 1383, 1451, 1444, and 1268). HIV recency testing was used to identify possible seroconversions in the window period prior to study entry. Structured interviews covering drug use histories, current drug use, and use of HIV-related services were administered by trained interviewers. Urinalysis was used to confirm current drug use. HIV and hepatitis C virus testing were conducted. Electronic fingerprint readers were used to avoid multiple participation in each survey and to link participants across surveys. A cohort of HIV seronegative participants with 6-month follow-up visits was recruited from the surveys, 480 from 2016, 233 from 2017, and 213 from 2018. Participants were predominantly male (95%), mean age approximately 40, all reported injecting heroin, HIV prevalence ranged between 26 and 30%. We had three seroconversions in 1483 person-years at risk (PYAR) in the cohort study, and 0 in 696 PYAR among repeat survey participants, and 0 seroconversions in 1344 PYAR in recency testing. Overall HIV incidence was 0.085/100 PYAR, 95% confidence interval 0.02-0.25/100 PYAR. The data from Hai Phong clearly demonstrate that it is possible to achieve very low HIV incidence - 'end an HIV epidemic' - among PWID in a middle-income country.
Identifiants
pubmed: 33048884
doi: 10.1097/QAD.0000000000002712
pii: 00002030-202012010-00015
pmc: PMC8608372
mid: NIHMS1643045
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2305-2311Subventions
Organisme : NIDA NIH HHS
ID : R01 DA003574
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA041978
Pays : United States
Références
JAMA. 1994 Jan 12;271(2):121-7
pubmed: 8264066
Int J Drug Policy. 2016 Jun;32:50-6
pubmed: 27006257
Curr Opin HIV AIDS. 2012 Mar;7(2):151-6
pubmed: 22227587
Drug Alcohol Depend. 2018 Apr 01;185:106-111
pubmed: 29432973
Nature. 1992 Dec 3;360(6403):410-2
pubmed: 1448163
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002209
pubmed: 19588333
AIDS Behav. 2014 Mar;18(3):443-51
pubmed: 24271348
Ir J Med Sci. 1990 May;159(5):141-4
pubmed: 2397983
Am J Public Health. 2016 Mar;106(3):503-8
pubmed: 26794160
PLoS One. 2009 Nov 11;4(11):e7558
pubmed: 19907649
Addict Sci Clin Pract. 2012;7:3
pubmed: 22966409
Mil Med. 1974 Feb;139(2):108-13
pubmed: 4204806
J Public Health Policy. 2018 May;39(2):217-230
pubmed: 29531303
Lancet. 2010 Aug 14;376(9740):532-9
pubmed: 20638713
Lancet. 2018 Sep 1;392(10149):714-716
pubmed: 30191815
AIDS. 1988 Feb;2(1):55-60
pubmed: 3128998
Lancet. 2018 Sep 1;392(10149):747-759
pubmed: 30191830
Euro Surveill. 2008 Dec 11;13(50):
pubmed: 19087869
AIDS Behav. 2003 Jun;7(2):131-41
pubmed: 14586198